Embecta Corp.
Embecta is a medical-device company focused on diabetes management and injection systems with minimal direct government dependence and low political profile.
BusinessWhat EMBC does
Embecta manufactures and distributes diabetes care devices, including pen needles, syringes, and infusion sets. Revenue is primarily driven by direct sales to healthcare providers, pharmacies, and patients in the US and international markets. The company has no material government contracts or Medicare/Medicaid rate dependence.
Executive Branch ConflictsEMBC held by Trump-administration officials
Lifetime Government AwardsEMBC federal contracts
EMBC doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding EMBC
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Open-market buys
Bills Affecting EMBCLive legislation impacting this stock
Political ProfileWhere EMBC sits in Washington
Embecta has no measurable lobbying footprint, zero politician trades, and no named legislative winners/losers. Stock movement is driven by clinical efficacy, reimbursement rates, and competitive dynamics rather than federal policy.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA reimbursement pressure
- state-level diabetes-supply price caps
Regulatory opportunities
- FDA 510(k) pathway streamlining
- Medicare coverage expansion for diabetes devices
Live signals + predictions for EMBC — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades EMBC
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord